14-16 June 2010
London, UK

Practical approaches to RMPs, PSUR and overarching pharmacovigilance strategies to enhance efficiency and safeguard patient safety

The importance of drug safety has never been more paramount. Patients’ attitudes to risk have changed immeasurably over the last few decades and negative perceptions of a treatment can destroy the reputation of its developer. Regulatory challenges and rule changes on risk management have also added to the pressures on drug developers to ensure sound pharmacovigilance processes are in place.

The conference will cover core topics including:

• Development and implementation of robust Risk Management Plans
• Different approaches to risk mitigation
• Preparing for inspections and being inspection ready at all times
• Taking the steps to standardising regulations and guidelines globally
• Preparing Periodic Safety Update Reports (PSUR) and improving future reporting
• Effective approaches to adverse event reporting and signal detection

The agenda is designed to help you:

• Improve the implementation of your risk management plans by learning best practice from Merck Serono, Bayer Schering Pharma, Solvay Pharmaceuticals and Johnson and Johnson
• Take away ideas on how to improve your inspection readiness with guidance from the Danish Medicines Agency and Novartis Consumer Health
• Learn how you can communicate more effectively with regulators, patients and prescribing physicians through proven strategies from Roche and the Icelandic Medicines Control Agency

Event only price: £1,499

For more information, please email enquire@iqpc.co.uk, call +44 (0)20 7368 9300 or visit the website.